2 ms·
The FDA does have that option and is doing it for this drug. It’s called a “National Coverage Determination” https://www.cms.gov/newsroom/press-releases/cms-o
by refurb 5y ago
The FDA does have that option and is doing it for this drug. It’s called a “National Coverage Determination”
https://www.cms.gov/newsroom/press-releases/cms-opens-national-coverage-determination-analysis-treatment-alzheimers-disease https://www.cms.gov/newsroom/press-releases/cms-opens-nation...
"Today, the Centers for Medicare & Medicaid Services (CMS) is opening a National Coverage Determination (NCD) analysis, a process that will allow the agency to carefully review and determine whether Medicare will establish a national Medicare coverage policy for monoclonal antibodies targeting amyloid for the treatment of Alzheimer’s disease."